Business

J&J Vaccine and Blood Clots: A Risk, if It Exists, Is Tiny


On Tuesday morning, U.S. federal health regulators recommended a pause in the use of Johnson & Johnson’s Covid-19 vaccine while they investigated six reports of blood clots in women ages 18 to 48. One has died, and a second is hospitalized in critical condition. As of Monday, 6.8 million people in …

Read more

Show More

Related Articles

Back to top button